Study Evaluating HKI-272 (Neratinib) In Subjects With Advanced Breast Cancer

Summary

The purpose of this study is to learn whether neratinib is safe and effective in treating women with advanced human epidermal growth factor receptor 2 (HER2) positive breast cancer.

Timeline

Start

2006-08-04

Primary completion

2008-04

Completion

2018-01-30

Drugs

Indications